Protein predicts prostate cancer spread.Prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. patients who harbor high concentrations of a protein called thymosine beta-15 in their tumors face an increased risk that the cancer will spread, new research shows. Researchers at Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. in Boston tracked 32 prostate cancer patients who received only radiation therapy. At the start of the study, the scientists measured the thymosine beta-15 concentrations in each man's tumor tissue. After 6 years, cancer had spread to bones in 8 of the 13 patients who had had high thymosine beta-15 concentrations, reports radiation oncologist radiation oncologist Radiation therapist A radiologist specialized in using radioactive substances and x-rays to treat tumors and CA; an oncologist who uses various formats of radiation to manage CA Salary ± $200K. See Oncologist. Arnab Chakravarti. In contrast, one of the eight patients who had had little of the protein had any tumor spread. Because prostate cancer's course varies, says Roy S. Weiner of Tulane University History Founding/early history The University dates from 1834 as the Medical College of Louisiana.<ref name="facts" /> With the addition of a law department, it became The University of Louisiana Medical Center in New Orleans, "anything that can home in on the prognosis of individual patients [and] guide us in clinical intervention is of tremendous value." |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion